AG
CDNA icon

Aperio Group’s CareDx CDNA Stock Holding History

Aperio Group’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$558K Buy
7,708
+1,332
+21% +$77.2K ﹤0.01% 1914
2020
Q3 		$242K Buy
+6,376
New +$215K ﹤0.01% 2153
2019
Q3 		– Sell
-866
Closed -$31K – 2382
2019
Q2 		$31K Buy
+866
New +$27.7K ﹤0.01% 2620

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Aperio Group's CDNA Position: Q4 2020 in Review

Aperio Group increased its CareDx (CDNA) stake by 21% in Q4 2020, buying an estimated $77.2K and bringing the position to 7,708 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

Aperio Group first reported a position in CDNA in Q2 2019 and has held it in 3 quarters since. 232 funds tracked by Wall St. Rank hold CDNA as of Q4 2020.

  • Aperio Group held 7,708 shares of CareDx worth $558K as of Q4 2020.
  • Aperio Group bought 1,332 CareDx shares in Q4 2020, an estimated $77.2K.
  • CareDx made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1914 holding.
  • Aperio Group first reported a position in CareDx in Q2 2019 and has held it in 3 quarters since.
  • 232 funds tracked by Wall St. Rank held CareDx as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.